Shares of Bioventix PLC (LON:BVXP) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 3,375 ($44.10) and last traded at GBX 3,375 ($44.10), with a volume of 3363 shares traded. The stock had previously closed at GBX 3,240 ($42.34).
Separately, FinnCap reiterated a “corporate” rating on shares of Bioventix in a research note on Monday, October 8th.
The firm also recently declared a dividend, which was paid on Friday, November 9th. Shareholders of record on Thursday, October 25th were paid a dividend of GBX 91 ($1.19) per share. The ex-dividend date was Thursday, October 25th. This is a positive change from Bioventix’s previous dividend of $25.00. This represents a yield of 2.98%.
ILLEGAL ACTIVITY WARNING: “Bioventix (BVXP) Reaches New 52-Week High at $3,375.00” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/11/30/bioventix-bvxp-reaches-new-52-week-high-at-3375-00.html.
About Bioventix (LON:BVXP)
Bioventix PLC, a biotechnology company, manufactures and supplies sheep monoclonal antibodies (SMAs) for use in diagnostics applications. The company offers a portfolio of purified SMAs for the clinical diagnostics market for thyroid, vitamin D, cardiovascular, drugs of abuse, fertility testing, infectious disease, oncology, and miscellaneous.
Featured Story: How Buying a Call Option Works
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.